Skip to main content
Top
Published in: Infectious Agents and Cancer 1/2012

Open Access 01-12-2012 | Research article

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study

Authors: Ane Cecilie Munk, Irene Tveiterås Øvestad, Einar Gudlaugsson, Kjell Løvslett, Bent Fiane, Bianca van Diermen-Hidle, Arnold-Jan Kruse, Ivar Skaland, Emiel AM Janssen, Jan PA Baak

Published in: Infectious Agents and Cancer | Issue 1/2012

Login to get access

Abstract

Background

The major cause of cervical intraepithelial neoplasia (CIN) is persistent infection with human papillomavirus (HPV). Most CIN grade 2 and 3 lesions are treated with cone excision, although a substantial proportion (6-50%) of CIN2-3 lesions will regresses spontaneously. Predictors for regression of CIN2-3 are desirable in order to reduce this overtreatment.

Methods

In this prospective cohort study, 145 consecutive women with first-time onset CIN2-3 in colposcopy-directed biopsies and standardized biopsy-cone excision interval were included. The genotype of the high-risk human papillomaviruses (=hr HPV) and clinical factors including sexual behaviour, parity, contraception and smoking were assessed. Patients were divided into two groups according to lesions containing HPV16 (hr HPV16+) and high-risk non-HPV16 (hr HPV16-) genotypes.

Results

Women whose partners consistently used condoms showed a significantly higher regression rate than women using other types of contraception (53% versus 13%, p<0.0001). However, this effect was only seen in hr HPV16- patients (73% regression rate versus 13%, p<0.0001). Hr HPV16+ patients had a significantly higher number of sexual partners and more current smokers compared to hr HPV16- patients. The regression rate was not significantly different in CIN2-3 lesions containing HPV16 (hr HPV16+) versus hr HPV16- genotypes.

Conclusions

Heterogeneity among hr HPV genotypes excists. HPV-genotype analyses can identify women who significantly increase their chance of regression by consistent condom use.
Appendix
Available only for authorised users
Literature
1.
go back to reference Coutlee F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL: Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol. 2011, 83 (6): 1034-1041. 10.1002/jmv.22081.PubMedCrossRef Coutlee F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL: Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol. 2011, 83 (6): 1034-1041. 10.1002/jmv.22081.PubMedCrossRef
2.
go back to reference Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189 (1): 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.PubMedCrossRef Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189 (1): 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.PubMedCrossRef
3.
go back to reference Bosch FX, de Sanjose S: Chapter 1: Human papillomavirus and cervical cancer–burden and assessment of causality. J Natl Cancer Inst Monogr. 2003, 31: 3-13.PubMedCrossRef Bosch FX, de Sanjose S: Chapter 1: Human papillomavirus and cervical cancer–burden and assessment of causality. J Natl Cancer Inst Monogr. 2003, 31: 3-13.PubMedCrossRef
4.
go back to reference Aral SO, Adimora AA, Fenton KA: Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008, 372 (9635): 337-340. 10.1016/S0140-6736(08)61118-6.PubMedCrossRef Aral SO, Adimora AA, Fenton KA: Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008, 372 (9635): 337-340. 10.1016/S0140-6736(08)61118-6.PubMedCrossRef
5.
go back to reference Syrjanen K, Hakama M, Saarikoski S, Vayrynen M, Yliskoski M, Syrjanen S, Kataja V, Castren O: Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis. 1990, 17 (1): 15-19.PubMedCrossRef Syrjanen K, Hakama M, Saarikoski S, Vayrynen M, Yliskoski M, Syrjanen S, Kataja V, Castren O: Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis. 1990, 17 (1): 15-19.PubMedCrossRef
6.
go back to reference Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338 (7): 423-428. 10.1056/NEJM199802123380703.PubMedCrossRef Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338 (7): 423-428. 10.1056/NEJM199802123380703.PubMedCrossRef
7.
go back to reference Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS: Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001, 357 (9271): 1831-1836. 10.1016/S0140-6736(00)04956-4.PubMedCrossRef Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS: Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001, 357 (9271): 1831-1836. 10.1016/S0140-6736(00)04956-4.PubMedCrossRef
8.
go back to reference Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992, 327 (18): 1272-1278. 10.1056/NEJM199210293271804.PubMedCrossRef Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992, 327 (18): 1272-1278. 10.1056/NEJM199210293271804.PubMedCrossRef
9.
go back to reference Rozendaal L, Westerga J, van der Linden JC, Walboomers JM, Voorhorst FJ, Risse EK, Boon ME, Meijer CJ: PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol. 2000, 53 (8): 606-611. 10.1136/jcp.53.8.606.PubMedPubMedCentralCrossRef Rozendaal L, Westerga J, van der Linden JC, Walboomers JM, Voorhorst FJ, Risse EK, Boon ME, Meijer CJ: PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol. 2000, 53 (8): 606-611. 10.1136/jcp.53.8.606.PubMedPubMedCentralCrossRef
10.
go back to reference Ostor AG: Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993, 12 (2): 186-192. 10.1097/00004347-199304000-00018.PubMedCrossRef Ostor AG: Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993, 12 (2): 186-192. 10.1097/00004347-199304000-00018.PubMedCrossRef
11.
go back to reference Nasiell K, Nasiell M, Vaclavinkova V: Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol. 1983, 61 (5): 609-614.PubMed Nasiell K, Nasiell M, Vaclavinkova V: Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol. 1983, 61 (5): 609-614.PubMed
12.
go back to reference Baak JP, Kruse AJ, Robboy SJ, Janssen EA, van Diermen B, Skaland I: Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol. 2006, 59 (10): 1017-1028. 10.1136/jcp.2005.027839.PubMedPubMedCentralCrossRef Baak JP, Kruse AJ, Robboy SJ, Janssen EA, van Diermen B, Skaland I: Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol. 2006, 59 (10): 1017-1028. 10.1136/jcp.2005.027839.PubMedPubMedCentralCrossRef
13.
go back to reference Ovestad IT, Gudlaugsson E, Skaland I, Malpica A, Kruse AJ, Janssen EA, Baak JP: Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2010, 23 (9): 1231-1240. 10.1038/modpathol.2010.109.CrossRef Ovestad IT, Gudlaugsson E, Skaland I, Malpica A, Kruse AJ, Janssen EA, Baak JP: Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2010, 23 (9): 1231-1240. 10.1038/modpathol.2010.109.CrossRef
14.
go back to reference International Collaboration of Epidemiological Studies of Cervical Cancer: Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009, 18 (4): 1060-1069.CrossRef International Collaboration of Epidemiological Studies of Cervical Cancer: Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009, 18 (4): 1060-1069.CrossRef
15.
go back to reference Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX: Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet. 2002, 359 (9312): 1093-1101. 10.1016/S0140-6736(02)08151-5.PubMedCrossRef Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX: Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet. 2002, 359 (9312): 1093-1101. 10.1016/S0140-6736(02)08151-5.PubMedCrossRef
16.
go back to reference Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Plummer M, Beral V: Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003, 361 (9364): 1159-1167. 10.1016/S0140-6736(03)12949-2.PubMedCrossRef Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Plummer M, Beral V: Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003, 361 (9364): 1159-1167. 10.1016/S0140-6736(03)12949-2.PubMedCrossRef
17.
go back to reference Trimble CL, Genkinger JM, Burke AE, Hoffman SC, Helzlsouer KJ, Diener-West M, Comstock GW, Alberg AJ: Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol. 2005, 105 (1): 174-181. 10.1097/01.AOG.0000148268.43584.03.PubMedPubMedCentralCrossRef Trimble CL, Genkinger JM, Burke AE, Hoffman SC, Helzlsouer KJ, Diener-West M, Comstock GW, Alberg AJ: Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol. 2005, 105 (1): 174-181. 10.1097/01.AOG.0000148268.43584.03.PubMedPubMedCentralCrossRef
18.
go back to reference Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, Wilgus B, Yutzy W, Daniel R, Shah K, et al: Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clinical cancer research: an official journal of the American Association for Cancer Research. 2005, 11 (13): 4717-4723. 10.1158/1078-0432.CCR-04-2599.CrossRef Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, Wilgus B, Yutzy W, Daniel R, Shah K, et al: Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clinical cancer research: an official journal of the American Association for Cancer Research. 2005, 11 (13): 4717-4723. 10.1158/1078-0432.CCR-04-2599.CrossRef
19.
go back to reference Wentzensen N, Walker J, Schiffman M, Yang HP, Zuna RE, Dunn ST, Allen RA, Zhang R, Sherman M, Gold MA, Wang SS: Heterogeneity of high grade cervical intraepithelial neoplasia related to HPV16: Implications for natural history and management. Int J Cancer. 2013 Jan 1, 132 (1): 148-154. 10.1002/ijc.27577.PubMedPubMedCentralCrossRef Wentzensen N, Walker J, Schiffman M, Yang HP, Zuna RE, Dunn ST, Allen RA, Zhang R, Sherman M, Gold MA, Wang SS: Heterogeneity of high grade cervical intraepithelial neoplasia related to HPV16: Implications for natural history and management. Int J Cancer. 2013 Jan 1, 132 (1): 148-154. 10.1002/ijc.27577.PubMedPubMedCentralCrossRef
20.
go back to reference Baak JP, Kruse AJ, Garland SM, Skaland I, Janssen EA, Tabrizi S, Fagerheim S, Robboy S, Nilsen ST: Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions. Am J Surg Pathol. 2005, 29 (8): 1062-1066.PubMed Baak JP, Kruse AJ, Garland SM, Skaland I, Janssen EA, Tabrizi S, Fagerheim S, Robboy S, Nilsen ST: Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions. Am J Surg Pathol. 2005, 29 (8): 1062-1066.PubMed
21.
go back to reference McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC: Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. The lancet oncology. 2008, 9 (5): 425-434. 10.1016/S1470-2045(08)70103-7.PubMedCrossRef McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC: Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. The lancet oncology. 2008, 9 (5): 425-434. 10.1016/S1470-2045(08)70103-7.PubMedCrossRef
22.
go back to reference Hagen B, Skjeldestad FE, Bratt H, Tingulstad S, Lie AK: CO2 laser conization for cervical intraepithelial neoplasia grade II-III: complications and efficacy. Acta Obstet Gynecol Scand. 1998, 77 (5): 558-563. 10.1080/j.1600-0412.1998.770515.x.PubMedCrossRef Hagen B, Skjeldestad FE, Bratt H, Tingulstad S, Lie AK: CO2 laser conization for cervical intraepithelial neoplasia grade II-III: complications and efficacy. Acta Obstet Gynecol Scand. 1998, 77 (5): 558-563. 10.1080/j.1600-0412.1998.770515.x.PubMedCrossRef
23.
go back to reference Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E: Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006, 367 (9509): 489-498. 10.1016/S0140-6736(06)68181-6.PubMedCrossRef Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E: Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006, 367 (9509): 489-498. 10.1016/S0140-6736(06)68181-6.PubMedCrossRef
24.
go back to reference Albrechtsen S, Rasmussen S, Thoresen S, Irgens LM, Iversen OE: Pregnancy outcome in women before and after cervical conisation: population based cohort study. BMJ. 2008, 337: a1343-10.1136/bmj.a1343.PubMedPubMedCentralCrossRef Albrechtsen S, Rasmussen S, Thoresen S, Irgens LM, Iversen OE: Pregnancy outcome in women before and after cervical conisation: population based cohort study. BMJ. 2008, 337: a1343-10.1136/bmj.a1343.PubMedPubMedCentralCrossRef
25.
go back to reference Barken SS, Rebolj M, Andersen ES, Lynge E: Frequency of cervical intraepithelial neoplasia treatment in a well-screened population. Int J Cancer. 2012, 130 (10): 2438-2444. 10.1002/ijc.26248.PubMedCrossRef Barken SS, Rebolj M, Andersen ES, Lynge E: Frequency of cervical intraepithelial neoplasia treatment in a well-screened population. Int J Cancer. 2012, 130 (10): 2438-2444. 10.1002/ijc.26248.PubMedCrossRef
26.
go back to reference Munk AC, Kruse AJ, van Diermen B, Janssen EA, Skaland I, Gudlaugsson E, Nilsen ST, Baak JP: Cervical intraepithelial neoplasia grade 3 lesions can regress. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2007, 115 (12): 1409-1414.PubMedCrossRef Munk AC, Kruse AJ, van Diermen B, Janssen EA, Skaland I, Gudlaugsson E, Nilsen ST, Baak JP: Cervical intraepithelial neoplasia grade 3 lesions can regress. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2007, 115 (12): 1409-1414.PubMedCrossRef
27.
go back to reference Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348 (6): 518-527. 10.1056/NEJMoa021641.PubMedCrossRef Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348 (6): 518-527. 10.1056/NEJMoa021641.PubMedCrossRef
28.
go back to reference Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F: Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6 (4): 204-10.1016/S1470-2045(05)70086-3.PubMedCrossRef Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F: Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6 (4): 204-10.1016/S1470-2045(05)70086-3.PubMedCrossRef
29.
go back to reference Kjaer SK, Frederiksen K, Munk C, Iftner T: Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010, 102 (19): 1478-1488. 10.1093/jnci/djq356.PubMedPubMedCentralCrossRef Kjaer SK, Frederiksen K, Munk C, Iftner T: Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010, 102 (19): 1478-1488. 10.1093/jnci/djq356.PubMedPubMedCentralCrossRef
30.
go back to reference Steen R, Johansen BK, Skare G, Haldorsen T, Eriksen T, Waage R, Molund IM: Annual Report Cervical Cancer Screening 2008. Cancer Registry of Norway. 2009 Steen R, Johansen BK, Skare G, Haldorsen T, Eriksen T, Waage R, Molund IM: Annual Report Cervical Cancer Screening 2008. Cancer Registry of Norway. 2009
31.
go back to reference WHO: IARC Classification of Tumors of the Breast and Female Genital Organs, vol. Book 4. 2003, IARCPress, Lyon WHO: IARC Classification of Tumors of the Breast and Female Genital Organs, vol. Book 4. 2003, IARCPress, Lyon
32.
go back to reference Kruse AJ, Baak JP, de Bruin PC, Jiwa M, Snijders WP, Boodt PJ, Fons G, Houben PW, The HS: Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol. 2001, 193 (1): 48-54. 10.1002/1096-9896(2000)9999:9999<::AID-PATH719>3.0.CO;2-E.PubMedCrossRef Kruse AJ, Baak JP, de Bruin PC, Jiwa M, Snijders WP, Boodt PJ, Fons G, Houben PW, The HS: Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol. 2001, 193 (1): 48-54. 10.1002/1096-9896(2000)9999:9999<::AID-PATH719>3.0.CO;2-E.PubMedCrossRef
33.
go back to reference Soreide K: Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol. 2009, 62 (1): 1-5. 10.1136/jcp.2008.061010.PubMedCrossRef Soreide K: Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol. 2009, 62 (1): 1-5. 10.1136/jcp.2008.061010.PubMedCrossRef
34.
go back to reference Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005, 97 (14): 1072-1079. 10.1093/jnci/dji187.PubMedCrossRef Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005, 97 (14): 1072-1079. 10.1093/jnci/dji187.PubMedCrossRef
35.
go back to reference Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121 (3): 621-632. 10.1002/ijc.22527.PubMedCrossRef Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121 (3): 621-632. 10.1002/ijc.22527.PubMedCrossRef
36.
go back to reference Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM: Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011, 128 (4): 927-935. 10.1002/ijc.25396.PubMedCrossRef Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM: Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011, 128 (4): 927-935. 10.1002/ijc.25396.PubMedCrossRef
37.
go back to reference Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, Westenend PJ, Meijer CJ: Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer. 2003, 107 (5): 811-816. 10.1002/ijc.11474.PubMedCrossRef Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, Westenend PJ, Meijer CJ: Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer. 2003, 107 (5): 811-816. 10.1002/ijc.11474.PubMedCrossRef
38.
go back to reference Rousseau MC, Franco EL, Villa LL, Sobrinho JP, Termini L, Prado JM, Rohan TE: A cumulative case–control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2000, 9 (5): 469-476. Rousseau MC, Franco EL, Villa LL, Sobrinho JP, Termini L, Prado JM, Rohan TE: A cumulative case–control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2000, 9 (5): 469-476.
39.
go back to reference Olsen AO, Dillner J, Skrondal A, Magnus P: Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology. 1998, 9 (3): 346-349. 10.1097/00001648-199805000-00022.PubMedCrossRef Olsen AO, Dillner J, Skrondal A, Magnus P: Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology. 1998, 9 (3): 346-349. 10.1097/00001648-199805000-00022.PubMedCrossRef
40.
go back to reference McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM: Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1992, 1 (2): 125-129. McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM: Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1992, 1 (2): 125-129.
41.
go back to reference Poppe WA, Peeters R, Daenens P, Ide PS, Van Assche FA: Tobacco smoking and the uterine cervix: cotinine in blood, urine and cervical fluid. Gynecol Obstet Invest. 1995, 39 (2): 110-114. 10.1159/000292390.PubMedCrossRef Poppe WA, Peeters R, Daenens P, Ide PS, Van Assche FA: Tobacco smoking and the uterine cervix: cotinine in blood, urine and cervical fluid. Gynecol Obstet Invest. 1995, 39 (2): 110-114. 10.1159/000292390.PubMedCrossRef
42.
go back to reference Lam TH, Stewart SM, Ho LM: Smoking and high-risk sexual behavior among young adults in Hong Kong. J Behav Med. 2001, 24 (5): 503-518. 10.1023/A:1012227728232.PubMedCrossRef Lam TH, Stewart SM, Ho LM: Smoking and high-risk sexual behavior among young adults in Hong Kong. J Behav Med. 2001, 24 (5): 503-518. 10.1023/A:1012227728232.PubMedCrossRef
43.
go back to reference Kelly RW: Immunosuppressive mechanisms in semen: implications for contraception. Hum Reprod. 1995, 10 (7): 1686-1693.PubMed Kelly RW: Immunosuppressive mechanisms in semen: implications for contraception. Hum Reprod. 1995, 10 (7): 1686-1693.PubMed
44.
go back to reference Wang X, Zhuang J, Wu K, Xu R, Li M, Lu Y: Human semen: the biological basis of sexual behaviour to promote human papillomavirus infection and cervical cancer. Med Hypotheses. 2010, 74 (6): 1015-1016. 10.1016/j.mehy.2010.01.009.PubMedCrossRef Wang X, Zhuang J, Wu K, Xu R, Li M, Lu Y: Human semen: the biological basis of sexual behaviour to promote human papillomavirus infection and cervical cancer. Med Hypotheses. 2010, 74 (6): 1015-1016. 10.1016/j.mehy.2010.01.009.PubMedCrossRef
45.
go back to reference Ovestad IT, Gudlaugsson E, Skaland I, Malpica A, Munk AC, Janssen EA, Baak JP: The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3. J Clin Pathol. 2011, 64 (4): 303-307. 10.1136/jcp.2010.083626.PubMedCrossRef Ovestad IT, Gudlaugsson E, Skaland I, Malpica A, Munk AC, Janssen EA, Baak JP: The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3. J Clin Pathol. 2011, 64 (4): 303-307. 10.1136/jcp.2010.083626.PubMedCrossRef
Metadata
Title
Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study
Authors
Ane Cecilie Munk
Irene Tveiterås Øvestad
Einar Gudlaugsson
Kjell Løvslett
Bent Fiane
Bianca van Diermen-Hidle
Arnold-Jan Kruse
Ivar Skaland
Emiel AM Janssen
Jan PA Baak
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2012
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/1750-9378-7-30

Other articles of this Issue 1/2012

Infectious Agents and Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine